P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias. (12th March 2014)

Record Type:: Journal Article
Title:: P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias. (12th March 2014)
Main Title:: P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias
Authors:: Richard, K
Schober, S
Rami, M
Mall, S
Merl, J
Slotta-Huspenina, J
Stevanovic, S
Busch, DH
Peschel, C
Krackhardt, AM
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 2(2014)Supplement 2
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 2(2014)Supplement 2
Issue Display:: Volume 2, Issue 2 (2014)
Year:: 2014
Volume:: 2
Issue:: 2
Issue Sort Value:: 2014-0002-0002-0000
Page Start:
Page End:
Publication Date:: 2014-03-12
Subjects:: Human Leukocyte Antigen -- Acute Myeloid Leukaemia -- Donor Lymphocyte Infusion -- Restricted Expression -- Bone Marrow Infiltration
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-2-S2-P43 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19198.xml